Gene · 3489
Papers1,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA expression profiles associated with the metastatic ability of MDA‑MB‑231 breast cancer cells. | Oncol Lett | 2023 | 37427352 | PubTator, text mining | PubMed |
| Mast Cell Tryptase Promotes Airway Remodeling by Inducing Anti-Apoptotic and Cell Growth Properties in Human Alveolar and Bronchial Epithelial Cells. | Cells | 2023 | 37408273 | PubTator, text mining | PubMed |
| Identification and analysis of cellular senescence-associated signatures in diabetic kidney disease by integrated bioinformatics analysis and machine learning. | Front Endocrinol (Lausanne) | 2023 | 37396184 | PubTator, text mining | PubMed |
| Genetics: A Starting Point for the Prevention and the Treatment of Obesity. | Nutrients | 2023 | 37375686 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome. | J Pers Med | 2023 | 37373974 | PubTator, text mining | PubMed |
| New Insights into Adipose Tissue Metabolic Function and Dysfunction. | Int J Mol Sci | 2023 | 37373101 | PubTator, text mining | PubMed |
| Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas. | Int J Mol Sci | 2023 | 37373068 | PubTator, text mining | PubMed |
| Epigenetic and Immunological Features of Bladder Cancer. | Int J Mol Sci | 2023 | 37373000 | PubTator, text mining | PubMed |
| Spinal cord injury: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37357239 | PubTator, text mining | PubMed |
| Microtubule stabilization targeting regenerative chondrocyte cluster for cartilage regeneration. | Theranostics | 2023 | 37351173 | PubTator, text mining | PubMed |
| Effect of IGFBP6 Knockdown on Proteins Regulating Exosome Synthesis and Secretion in MDA-MB-231 Cell Line. | Bull Exp Biol Med | 2023 | 37336811 | PubTator, text mining | PubMed |
| Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease. | BMC Nephrol | 2023 | 37331957 | PubTator, text mining | PubMed |
| Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function. | J Transl Med | 2023 | 37301958 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal changes in cell heterogeneity during progression of human tendinopathy. | BMC Biol | 2023 | 37280595 | PubTator, text mining | PubMed |
| Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations. | Nat Commun | 2023 | 37253714 | PubTator, text mining | PubMed |
| Association between IGFBP1 expression and cancer risk: A systematic review and meta-analysis. | Heliyon | 2023 | 37251476 | PubTator, text mining | PubMed |
| Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples. | Biomedicines | 2023 | 37238925 | PubTator, text mining | PubMed |
| Further Evidence that an Episode of Premature Labor Is a Pathologic State: Involvement of the Insulin-Like Growth Factor System. | Fetal Diagn Ther | 2023 | 37231893 | PubTator, text mining | PubMed |
| Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates. | Front Bioeng Biotechnol | 2023 | 37229499 | PubTator, text mining | PubMed |
| Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer. | Transl Oncol | 2023 | 37207381 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3489/papers?page=9